What is BostonSight?
BostonSight is a world-renowned nonprofit eye healthcare organization dedicated to improving the quality of life for patients with complex corneal diseases. Since its inception in 1992, the company has been instrumental in restoring sight for thousands globally. Its Needham, MA Center of Excellence houses a Medical Institute, Research Center, a state-of-the-art Manufacturing Lab, and a Patient and Family Support Center, all operating with a core philosophy of compassionate care. A key offering is the BostonSight PROSE Treatment, a custom-fitted prosthetic device designed to restore vision, alleviate pain, and reduce light sensitivity for individuals suffering from severe corneal conditions. This advanced treatment is disseminated worldwide through the BostonSight PROSE Provider Network at leading academic medical centers.
How much funding has BostonSight raised?
BostonSight has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for BostonSight?
The recent large-scale, late-stage funding marks a pivotal moment for BostonSight, signaling strong investor confidence in its mission and innovative PROSE treatment. This strategic backing is expected to accelerate the organization's research and development initiatives, expand its global reach, and enhance its manufacturing capabilities for prosthetic devices. The capital will likely be deployed to further refine treatment protocols, broaden the PROSE Provider Network, and potentially explore new therapeutic avenues for corneal diseases, solidifying BostonSight's leadership in the field of restorative eye care.
See full BostonSight company page
